
Bio Break: How Ablation Technology Is Transforming Surgery
In this episode of Bio Break, Nick Allan and Joris van der Heijden dive into one of the most impactful trends in modern medtech: minimally invasive surgery. Ablation technology plays a crucial role as hospitals and healthcare providers aim to reduce patient recovery times and overall system strain. Technologies like ablation have emerged as a powerful tool for treating conditions once requiring intensive surgeries.
Joris explains how ablation enables tissue removal without the need for large incisions. Whether it’s chemical, electrical, or thermal ablation, these methods allow clinicians to precisely target and destroy problematic tissues. The result? Less time in the hospital, faster healing, and a more comfortable experience for patients. Nick shares that while he once expected such treatments to be reserved for serious operations, technologies like ablation are now being used in areas like tumor removal, pain management, and cardiac arrhythmia treatment.
The two highlight how a flexible catheter can navigate the body to reach affected tissue sites without opening up the patient. From chronic back pain to small tumor removal, ablation technology delivers precise, targeted therapy with far fewer complications than traditional surgical procedures.
But with all its benefits, ablation isn’t without its limitations. Because the body isn’t fully opened up, visibility is limited—requiring more sophisticated imaging technologies to guide the process. As Joris points out, this often restricts the procedure to larger clinical centers, but the benefits to both patients and the healthcare system are still profound.
Whether you’re a developer of medical technologies, a healthcare provider, or simply curious about how next-gen surgical tools are reshaping patient care, this episode covers the significance of ablation technology and offers an informative and approachable look at a high-impact innovation.
Related Resources

In this Before the Build episode, Eric Olson and Paul Charlebois reflect on the value of patient-centered field research—and how firsthand observation can reframe design priorities and impact outcomes in profound ways.

Each summer, the laboratory diagnostics showcase hosted by the Association for Diagnostics & Laboratory Medicine (ADLM) draws industry leaders to Chicago.

Nigel and Nick explore how contrast agents in imaging support medical device trials and diagnostics. While bones appear clearly in standard X-rays, soft tissues like those in the nasal cavity often require contrast agents to become visible.

What does empathetic medical design really look like in practice? Eric and Paul discuss how emotional insight from field research can profoundly impact the design of medical devices